Hodgkin's disease in 63 intravenous drug users infected with human immunodeficiency virus

S. Monfardini, U. Tirelli, E. Vaccher, R. Foa, F. Gavosto

Research output: Contribution to journalArticle

Abstract

Sixty-three cases of Hodgkin's disease in intravenous drug users (IVDUs) have been collected by the Italian Cooperative Group on AIDS-Related Tumors (GICAT). In most patients (74%) the histological pattern was that of mixed cellularity and lymphocyte depletion. In 39% of patients the initial symptom was a persistent lymph node enlargement due to persistent generalized lymphadenopathy (PGL). Unusual presentations included Waldeyer's ring, skin, meninges, colon, and pleura. After MOPP alternated or followed by ABVD, MOPP alone, or ABVD alone, 15 of 32 patients (47%) had a complete remission (CR) and 15 of 32 (47%) had a partial remission (PR). The median duration of CR was 14 months, while the median survival of patients with CR has not been reached; the median survival of patients treated with chemotherapy who had CD4 levels at presentation ≥ 400/mm 3 was significantly superior to that of those who had CD4 <400/mm 3. The overall median survival was only 14 months. Forty-four percent of patients receiving chemotherapy, with or without radiotherapy, developed opportunistic as well as nonopportunistic infections. Lethal hepatic toxicity was observed in one patient. Among IVDUs, unusual presentations of Hodgkin's disease occurred at a lower rate than was previously reported for homosexuals. Complete remissions could be achieved in almost half the patients, but non opportunistic infections, in addition to parenchymal function impairment due to drug abuse, may limit treatment administration in IVDUs.

Original languageEnglish
Pages (from-to)201-205
Number of pages5
JournalAnnals of Oncology
Volume2
Issue numberSUPPL. 2
Publication statusPublished - 1991

Fingerprint

Drug Users
Hodgkin Disease
HIV
Survival
Lymphocyte Depletion
Drug Therapy
Meninges
Pleura
Opportunistic Infections
Intravenous Administration
Substance-Related Disorders
Colon
Acquired Immunodeficiency Syndrome
Radiotherapy
Lymph Nodes
Skin
Liver
Infection
Neoplasms

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Monfardini, S., Tirelli, U., Vaccher, E., Foa, R., & Gavosto, F. (1991). Hodgkin's disease in 63 intravenous drug users infected with human immunodeficiency virus. Annals of Oncology, 2(SUPPL. 2), 201-205.

Hodgkin's disease in 63 intravenous drug users infected with human immunodeficiency virus. / Monfardini, S.; Tirelli, U.; Vaccher, E.; Foa, R.; Gavosto, F.

In: Annals of Oncology, Vol. 2, No. SUPPL. 2, 1991, p. 201-205.

Research output: Contribution to journalArticle

Monfardini, S, Tirelli, U, Vaccher, E, Foa, R & Gavosto, F 1991, 'Hodgkin's disease in 63 intravenous drug users infected with human immunodeficiency virus', Annals of Oncology, vol. 2, no. SUPPL. 2, pp. 201-205.
Monfardini, S. ; Tirelli, U. ; Vaccher, E. ; Foa, R. ; Gavosto, F. / Hodgkin's disease in 63 intravenous drug users infected with human immunodeficiency virus. In: Annals of Oncology. 1991 ; Vol. 2, No. SUPPL. 2. pp. 201-205.
@article{4c06f3695a2b42359aba771e0b1547cd,
title = "Hodgkin's disease in 63 intravenous drug users infected with human immunodeficiency virus",
abstract = "Sixty-three cases of Hodgkin's disease in intravenous drug users (IVDUs) have been collected by the Italian Cooperative Group on AIDS-Related Tumors (GICAT). In most patients (74{\%}) the histological pattern was that of mixed cellularity and lymphocyte depletion. In 39{\%} of patients the initial symptom was a persistent lymph node enlargement due to persistent generalized lymphadenopathy (PGL). Unusual presentations included Waldeyer's ring, skin, meninges, colon, and pleura. After MOPP alternated or followed by ABVD, MOPP alone, or ABVD alone, 15 of 32 patients (47{\%}) had a complete remission (CR) and 15 of 32 (47{\%}) had a partial remission (PR). The median duration of CR was 14 months, while the median survival of patients with CR has not been reached; the median survival of patients treated with chemotherapy who had CD4 levels at presentation ≥ 400/mm 3 was significantly superior to that of those who had CD4 <400/mm 3. The overall median survival was only 14 months. Forty-four percent of patients receiving chemotherapy, with or without radiotherapy, developed opportunistic as well as nonopportunistic infections. Lethal hepatic toxicity was observed in one patient. Among IVDUs, unusual presentations of Hodgkin's disease occurred at a lower rate than was previously reported for homosexuals. Complete remissions could be achieved in almost half the patients, but non opportunistic infections, in addition to parenchymal function impairment due to drug abuse, may limit treatment administration in IVDUs.",
author = "S. Monfardini and U. Tirelli and E. Vaccher and R. Foa and F. Gavosto",
year = "1991",
language = "English",
volume = "2",
pages = "201--205",
journal = "Annals of Oncology",
issn = "0923-7534",
publisher = "NLM (Medline)",
number = "SUPPL. 2",

}

TY - JOUR

T1 - Hodgkin's disease in 63 intravenous drug users infected with human immunodeficiency virus

AU - Monfardini, S.

AU - Tirelli, U.

AU - Vaccher, E.

AU - Foa, R.

AU - Gavosto, F.

PY - 1991

Y1 - 1991

N2 - Sixty-three cases of Hodgkin's disease in intravenous drug users (IVDUs) have been collected by the Italian Cooperative Group on AIDS-Related Tumors (GICAT). In most patients (74%) the histological pattern was that of mixed cellularity and lymphocyte depletion. In 39% of patients the initial symptom was a persistent lymph node enlargement due to persistent generalized lymphadenopathy (PGL). Unusual presentations included Waldeyer's ring, skin, meninges, colon, and pleura. After MOPP alternated or followed by ABVD, MOPP alone, or ABVD alone, 15 of 32 patients (47%) had a complete remission (CR) and 15 of 32 (47%) had a partial remission (PR). The median duration of CR was 14 months, while the median survival of patients with CR has not been reached; the median survival of patients treated with chemotherapy who had CD4 levels at presentation ≥ 400/mm 3 was significantly superior to that of those who had CD4 <400/mm 3. The overall median survival was only 14 months. Forty-four percent of patients receiving chemotherapy, with or without radiotherapy, developed opportunistic as well as nonopportunistic infections. Lethal hepatic toxicity was observed in one patient. Among IVDUs, unusual presentations of Hodgkin's disease occurred at a lower rate than was previously reported for homosexuals. Complete remissions could be achieved in almost half the patients, but non opportunistic infections, in addition to parenchymal function impairment due to drug abuse, may limit treatment administration in IVDUs.

AB - Sixty-three cases of Hodgkin's disease in intravenous drug users (IVDUs) have been collected by the Italian Cooperative Group on AIDS-Related Tumors (GICAT). In most patients (74%) the histological pattern was that of mixed cellularity and lymphocyte depletion. In 39% of patients the initial symptom was a persistent lymph node enlargement due to persistent generalized lymphadenopathy (PGL). Unusual presentations included Waldeyer's ring, skin, meninges, colon, and pleura. After MOPP alternated or followed by ABVD, MOPP alone, or ABVD alone, 15 of 32 patients (47%) had a complete remission (CR) and 15 of 32 (47%) had a partial remission (PR). The median duration of CR was 14 months, while the median survival of patients with CR has not been reached; the median survival of patients treated with chemotherapy who had CD4 levels at presentation ≥ 400/mm 3 was significantly superior to that of those who had CD4 <400/mm 3. The overall median survival was only 14 months. Forty-four percent of patients receiving chemotherapy, with or without radiotherapy, developed opportunistic as well as nonopportunistic infections. Lethal hepatic toxicity was observed in one patient. Among IVDUs, unusual presentations of Hodgkin's disease occurred at a lower rate than was previously reported for homosexuals. Complete remissions could be achieved in almost half the patients, but non opportunistic infections, in addition to parenchymal function impairment due to drug abuse, may limit treatment administration in IVDUs.

UR - http://www.scopus.com/inward/record.url?scp=0025970216&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025970216&partnerID=8YFLogxK

M3 - Article

C2 - 1710920

AN - SCOPUS:0025970216

VL - 2

SP - 201

EP - 205

JO - Annals of Oncology

JF - Annals of Oncology

SN - 0923-7534

IS - SUPPL. 2

ER -